pubmed-article:19487069 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0026764 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0021083 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0544452 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C1521991 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0728938 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0205197 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:19487069 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:19487069 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:19487069 | pubmed:dateCreated | 2009-6-22 | lld:pubmed |
pubmed-article:19487069 | pubmed:abstractText | To investigate post-transplant immunotherapy with escalating donor-lymphocyte infusions (DLI) and novel agents (thalidomide, bortezomib, and lenalidomide) to target complete remission (CR). | lld:pubmed |
pubmed-article:19487069 | pubmed:language | eng | lld:pubmed |
pubmed-article:19487069 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19487069 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19487069 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19487069 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19487069 | pubmed:month | Jul | lld:pubmed |
pubmed-article:19487069 | pubmed:issn | 1873-2399 | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:CorradiniPaol... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:NaglerArnonA | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:ShimoniAvicha... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:KrögerNicolau... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:ZabelinaTatja... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:FehseBorisB | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:AyukFrancisF | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:AtanackovicDj... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:SchillingGeor... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:ZanderAxelA | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:SchwarzSabine... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:LioznovMichae... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:BacherUlrikeU | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:BadbaranAnita... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:KlyuchnikovEv... | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:ZeschkeSilkeS | lld:pubmed |
pubmed-article:19487069 | pubmed:author | pubmed-author:HildebrandYor... | lld:pubmed |
pubmed-article:19487069 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19487069 | pubmed:volume | 37 | lld:pubmed |
pubmed-article:19487069 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19487069 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19487069 | pubmed:pagination | 791-8 | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:meshHeading | pubmed-meshheading:19487069... | lld:pubmed |
pubmed-article:19487069 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19487069 | pubmed:articleTitle | Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma. | lld:pubmed |
pubmed-article:19487069 | pubmed:affiliation | Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. nkroeger@uke.uni-hamburg.de | lld:pubmed |
pubmed-article:19487069 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19487069 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19487069 | lld:pubmed |